SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000819050-20-000017
Filing Date
2020-02-10
Accepted
2020-02-10 16:56:46
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a202002s3.htm S-3 622023
2 EXHIBIT 4.2 a202002s3exhibit42.htm EX-4.2 384601
3 EXHIBIT 5.1 a202002s3exhibit51.htm EX-5.1 28220
4 EXHIBIT 23.1 a202002s3exhibit231.htm EX-23.1 3880
5 bbi_1.gif GRAPHIC 27959
6 bbi_2.gif GRAPHIC 25688
7 mblogoa02.gif GRAPHIC 4449
  Complete submission text file 0000819050-20-000017.txt   1120079
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-236353 | Film No.: 20592724
SIC: 2836 Biological Products, (No Diagnostic Substances)